Functioning Adrenocortical Oncocytic Carsinoma: A Case Report

Murat Atmaca, Saliha Yıldız, Işılay Kalan, Mehmet Fatih Özbay, Deniz Yılmaz, Müge Kara Tanrıtanır, Mustafa Öztürk

Department of Pathology, Yuzuncu Yil University, Van, Turkey.
Medipol University, Faculty of Medicine, Department of Endocrinology and Metabolism, ?stanbul, Turkey.
Van Education and Research Hospital, Department of Internal Medicine, Van, Turkey.
Yuzuncu Yil University, Faculty of Medicine, Department of Endocrinology and Metabolism, Van, Turkey.

DOI: 10.4236/ojemd.2013.31006                

Abstract

Introduction: Oncocytic neoplasms of the adrenal cortex are extremely rare and are usually nonfunctioning. Only a little more than fifty cases have been described in the literature. Case Presentation: We report the case of an adrenocortical oncocytic neoplasm with malignant potential in a 21-year-old female with co-secrete testosterone and cortisol. The patient had been operated of adrenal mass. Fallowing operation, the Cushing’s syndrome and high testosterone levels resolved. Conclusion: In our knowledge this is the first case in the l?terature which co-secret cortizol and testosterone in malign oncystoma.

Keywords

Oncocytoma; Cortisol; Testosterone

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	H. Hamperl, “Onkocytes and the so Called Hurthle Cell Tumor,” Archives of Pathology, Vol. 49, 1950, pp. 563-570.
[2]	A. Chang and S. J. Harawi, “Oncocytes, Oncytosis and Oncytotic Tumors,” Pathology Annual, Vol. 27, No. 1, 1992, pp. 263-304.
[3]	S. Kakimoto, Y. Yushita, T. Sanefugi, A. Kondo, N. Fujishima, M. Kishikawa, et al., “Non-Hormonal Adrenocortical Ademona with Oncocytoma Like Appearances,” Hinyokika Kiyo. Acta Urologica Japonica, Vol. 32, No. 5, 1986, pp. 757-763.
[4]	X. J. Tian,Y. Huang, J. Lu and L. L. Ma, “Laparoscopic Adrenocortical Oncocytoma Resection,” Chinese Medical Journal, Vol. 121, No. 9, 2008, pp. 862-864.
[5]	Z. W. Baloch and V. A. LiVolsi, “Oncocytic Lesions of the Neuroendocrine System,” Seminars in Diagnostic Pathology, Vol. 16, No. 2, 1999, pp. 190-199.
[6]	B. T. Lin, S. M. Bonsib, G. W. Mierau, L. M. Weiss and L. J. Medeiros, “Oncocytic Adrenal Neoplasms: A Report of Seven Cases and Review of the Literature,” The American Journal of Surgical Pathology, Vol. 22, No. 5, 1998, pp. 603-614. doi:10.1097/00000478-199805000-00012
[7]	D. Botsios, K. Blouhos, K. Vasiliadis, A. Asimaki, K. Tsalis and D. Betsis, “Adrenocortical Oncocytoma: A Rare Tumor of Undefined Malignant Potential,” Surgery Today, Vol. 37, No. 7, 2007, pp. 612-617. doi:10.1007/s00595-006-3458-4
[8]	G. Mikuz, “Clinical Pathology of Urologic Tumors,” CRC Press, Boca Raton, 2007.
[9]	M. N. Morra and S. Das, “Renal Oncocytoma: A Review of Histogenesis, Histopathology, Diagnosis and Treatment,” Journal of Urology, Vol. 150, No. 2, 1993, pp. 295-302.
[10]	G. K. Nguyen, R. Vriend, D. Ronagham and W. H. Lakey, “Heterotopic Adrenocortical Oncocytoma: A Case Report with Light and Electron Microscopic Studies,” Cancer, Vol. 70, No. 11, 1992, pp. 2681-2684. doi:10.1002/1097-0142(19921201)70:11<2681::AID-CNCR2820701119>3.0.CO;2-H
[11]	J. R. Goldblum, R. Shannon, E. P. Kaldjian, M. Thiny, R. Davenport, N. Thompson and R. V. Lloyd, “Immunohistochemical Assessment of Proliferative Activity in Adrenocortical Neoplasms,” Modern Pathology, Vol. 6, No. 6, 1993, pp. 663-668.
[12]	M. P. Vargas, H. I. Vargas, D. E. Kleiner and M. J. Merino, “Adrenocortical Neoplasms: Role of Prognostic Markers MIB-1, P53 and RB,” The American Journal of Surgical Pathology, Vol. 21, No. 5, 1997, pp. 556-562. doi:10.1097/00000478-199705000-00008
[13]	J. S. Winston, A. Mompoint, H. Wang and D. Crossland, “The Utility of Ki-67 in the Evaluation of Adrenocortical Neoplasms,” Modern Pathology, Vol. 10, 1997, p. 52A.
[14]	M. Bisceglia, O. Ludovico, A. Di Mattia, D. Ben-Dor, J. Sandbank, G. Pasquinelli, S. K. Lau and L. M. Weiss, “Adrenocortical Oncocytic Tumors: Report of 10 Cases and Review of the Literature,” International Journal of Surgical Pathology, Vol. 12, No. 3, 2004, pp. 231-243. doi:10.1177/106689690401200304
[15]	S. Krishnamurthy, N. G. Ordonez, T. O. Shelton, A. G. Ayala and N. Sneige, “Fine-Needle Aspiration Cytology of a Case of Oncocytic Adrenocortical Carcinoma,” Diagnostic Cytopathology, Vol. 22, No. 5, 2000, pp. 299-303. doi:10.1002/(SICI)1097-0339(200005)22:5<299::AID-DC8>3.0.CO;2-5
[16]	M. P. Hoang, A. G. Ayala and J. Albores-Saavedra, “Oncocytic Adrenocortical Carcinoma: A Morphologic, Immunohistochemical and Ultrastructural Study of Four Cases,” Modern Pathology, Vol. 15, No. 9, 2002, pp. 973-978. doi:10.1038/modpathol.3880638
[17]	A. K. El-Naggar, D. B. Evans and B. Mackay, “Oncocytic Adrenal Cortical Carcinoma,” Ultrastructural Pathology, Vol. 15, No. 4-5, 1991, pp. 549-556. doi:10.3109/01913129109016262
[18]	R. Kurek, R. Von Knobloch, U. Feek, A. Heidenreich and R. Hofmann, “Local Recurrence of an Oncocytic Adrenocortical Carcinoma with Ovary Metastasis,” Journal of Urology, Vol. 166, No. 3, 2001, p. 985. doi:10.1016/S0022-5347(05)65882-X
[19]	F. Go?kowski, M. Buziak-Bereza, B, Huszno, A. Ba?dys-Waligórska, A. Stefańska, A. Budzyński, K. Okoń, R. Chrzan and A. Urbanik, “The Unique Case of Adrenocortical Malignant and Functioning Oncocytic Tumour,” Experimental and Clinical Endocrinology & Diabetes, Vol. 115 No. 6, 2007 pp. 401-404. doi:10.1055/s-2007-967083
[20]	L. M. Weiss, L. J. Medeiros and A. L. Vickery Jr., “Pathologic Features of Prognostic Significance in Adrenocortical Carcinoma,” The American Journal of Surgical Pathology, Vol. 13, No. 3, 1989, pp. 202-206. doi:10.1097/00000478-198903000-00004
[21]	E. J. Gandras, L. H. Schwartz, D. M. Panicek and G. Levi, “Case Report. Adrenocortical Oncocytoma: CT and MRI Findings,” Journal of Computer Assisted Tomography, Vol. 20, No. 3, 1996, pp. 407-409. doi:10.1097/00004728-199605000-00016
[22]	D. J. Kim, J. J. Chung, Y. H. Ryu, S. W. Hong, J. S. Yu, and J. H. Kim, “Adrenocortical Oncocytoma Displaying Intense Activity on 18F-FDG-PET: A Case Report and a Literature Review,” Annals of Nuclear Medicine, Vol. 22 No. 9, 2008, pp. 821-824. doi:10.1007/s12149-008-0199-z
[23]	B. Allolio and M. Fassnacht, “Clinical Review: Adrenocortical Carcinoma: Clinical Update,” The Journal of Clinical Endocrinology & Metabolism, Vol. 91, No. 6, 2006, pp. 2027-2037. doi:10.1210/jc.2005-2639
[24]	C. I. M. van Ditzhuijsen, R. van de Weijer and H. R. Haak, “Adrenocortical Carcinoma,” Netherlands Journal of Medicine, Vol. 65, No. 2, 2007, pp. 55-60.